Navidea Biopharma (NAVB) Denied Request for Temp. Injunctive Relief in CRG Case; Alt. Financing Arrangements Made
Tweet Send to a Friend
Navidea Biopharma (NYSE: NAVB) disclosed the following on Tuesday night:Item 2.04 Triggering Events That Accelerate or ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
